Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Filana TherapeuticsFLNA | Open-market buy | 09/29–09/30 | 10/01 | 306,813 sh2 trades | $0.91avg. | $278,131.7 | +29.8% | |
Richard BarryPresident & CEO | Filana TherapeuticsFLNA | Open-market buy | 09/28 | 09/30 | 93,091 sh | $0.84 | $78,196.44 | +9.9% |